These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9476147)

  • 1. Clinical relevance of P-glycoprotein with respect to the application of resistance modifiers.
    Scheulen ME
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):41-5. PubMed ID: 9476147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Overcoming the multiple drug resistance of tumors].
    Donenko FV; Sitdikova SM; Moroz LV
    Vopr Onkol; 1991; 37(11-12):1034-41. PubMed ID: 1688278
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug resistance in hematologic malignancies.
    Dalton W
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):267-8. PubMed ID: 16166998
    [No Abstract]   [Full Text] [Related]  

  • 4. [Calcium antagonist as biological modulator in cancer chemotherapy].
    Tsuruo T
    Nihon Rinsho; 1989 Aug; 47(8):1851-6. PubMed ID: 2573744
    [No Abstract]   [Full Text] [Related]  

  • 5. [The molecular mechanisms of the multiple drug resistance of tumors].
    Leont'eva OV
    Antibiot Khimioter; 1995 May; 40(5):48-60. PubMed ID: 8534182
    [No Abstract]   [Full Text] [Related]  

  • 6. Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.
    Fox E; Bates SE
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):447-59. PubMed ID: 17428165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncobiogram and its significance in the choice and efficacy of cytostatic therapy].
    Savran VR
    Vopr Onkol; 1983; 29(3):106-13. PubMed ID: 6340347
    [No Abstract]   [Full Text] [Related]  

  • 8. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance reversal agents.
    Robert J; Jarry C
    J Med Chem; 2003 Nov; 46(23):4805-17. PubMed ID: 14584929
    [No Abstract]   [Full Text] [Related]  

  • 10. [Update on mechanisms of drug resistance].
    Chauffert B; Correia M; Sergent C
    Bull Cancer; 1999 Jan; 86(1):97-103. PubMed ID: 10029712
    [No Abstract]   [Full Text] [Related]  

  • 11. Modeling therapy resistance in genetically engineered mouse cancer models.
    Rottenberg S; Jonkers J
    Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction: chemotherapies in the treatment of breast cancer.
    Fojo AT
    Semin Oncol; 2005 Dec; 32(6 Suppl 7):S1-2. PubMed ID: 16360715
    [No Abstract]   [Full Text] [Related]  

  • 13. Calculated resistance in cancer.
    Sawyers CL
    Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
    [No Abstract]   [Full Text] [Related]  

  • 14. Minicells mitigate tumor growth.
    Dorans K
    Lab Anim (NY); 2009 Aug; 38(8):250. PubMed ID: 19626008
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
    Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanisms of the occurrence of tumor drug resistance and ways to overcome it].
    Belousova AK
    Vopr Onkol; 1978; 24(5):92-104. PubMed ID: 351956
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditions of drug delivery within solid tumors, and noninvasive methods for studies in humans.
    Port RE
    Int J Clin Pharmacol Ther; 1997 Feb; 35(2):78-9. PubMed ID: 9147714
    [No Abstract]   [Full Text] [Related]  

  • 19. [Segidrin: a new-type antineoplastic agent].
    Filov VA
    Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
    [No Abstract]   [Full Text] [Related]  

  • 20. Resisting resistance.
    Ewan S
    Drug Discov Today; 2005 Aug; 10(15):1015. PubMed ID: 16055015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.